Acorda Therapeutics Incの簿価
Acorda Therapeutics Incの簿価 は何ですか。
Acorda Therapeutics Incの簿価 は-8.21です。
簿価 の定義は何ですか。
1株当たりの帳簿価額は、会社の資産から会社の負債を差し引いた数を発行済株式数で割ったものです。
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
NASDAQのセクタHealth Careにおける簿価 の企業と比べるAcorda Therapeutics Inc
Acorda Therapeutics Incは何をしますか。
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Acorda Therapeutics Incと類似の簿価
- Opto Circuits (India)の簿価 は-8.45です。
- California Resources Corpの簿価 は-8.41です。
- MBIAの簿価 は-8.37です。
- Dynavisionの簿価 は-8.27です。
- Vivint Smart Home Incの簿価 は-8.24です。
- Rusoro Miningの簿価 は-8.22です。
- Acorda Therapeutics Incの簿価 は-8.21です。
- Town Sports Internationalの簿価 は-8.11です。
- MDC Partnersの簿価 は-8.06です。
- Ansal Properties & Infrastructureの簿価 は-8.05です。
- Lanesborough Real Estate Investment Trustの簿価 は-8.04です。
- Mechel PJSCの簿価 は-7.79です。
- Setco Automotiveの簿価 は-7.77です。